CD4 and neoplasm: Although the proliferation read out for total T cells was shown in the DC suppression assay, we found that both CD4+ and CD8+ T cells proliferated substantially higher than the negative control in all the four groups of mice, demonstrating that BMDCs presented tumor antigen to both CD4+ T cells and CD8+ T cells in an unbiased way, ex-vivo.